Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.

Bioorg Med Chem 2014 Jun 13;22(11):2947-54. Epub 2014 Apr 13.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People's Republic of China. Electronic address:

A series of 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety (3a-3r) has been designed, synthesized and their biological activities were also evaluated as potential antiproliferation and focal adhesion kinase (FAK) inhibitors. Among all the compounds, 3p showed the most potent activity in vitro which inhibited the growth of A549 with IC50 value of 3.11 μM and Hela with IC50 value of 2.54 μM respectively. Compound 3p also exhibited significant FAK inhibitory activity (IC50=0.45 μM). Docking simulation was performed for compound 3p into the FAK structure active site to determine the probable binding model.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2014.04.005DOI Listing
June 2014
92 Reads

Publication Analysis

Top Keywords

2-styryl-5-nitroimidazole derivatives
8
fak inhibitors
8
14-benzodioxan moiety
8
derivatives 14-benzodioxan
8
ic50 311
4
254 μm
4
311 μm
4
ic50 254
4
a549 ic50
4
μm hela
4
hela ic50
4
inhibited growth
4
adhesion kinase
4
focal adhesion
4
antiproliferation focal
4
potential antiproliferation
4
kinase fak
4
compounds potent
4
vitro inhibited
4
activity vitro
4

Similar Publications